Sephira Med · Bay Street board
Read the card. Then ask the person who wrote the script.
We pin what the leaflet and the named trial actually say. Brands stay tied to molecules. The desk does not fill a box or take your chart.
Signals on the rail
Short notes on meals, brands, taper steps, and ward flags. Read them next to the full panel, not instead of it.
Posted panels
One molecule per card. A trade name shows up only when patients already know it from the blister.











PDE5 match board
Three oral clocks on one sheet so daily tadalafil, meal-timed sildenafil, and QT-screened vardenafil stop getting mixed in the same sentence.
Daily Cialis, the Viagra 25-100 ladder, and Levitra 2.5-20 on one review sheet
Sephira reviews three oral PDE5 ranges that already sit on the Toronto panels: tadalafil 2.5 mg or 5 mg once daily, sildenafil 25-50-100 mg as needed, and vardenafil from a 2.5 mg start through 20 mg. Weekend tadalafil 2
Board guide
Dr. Yuki Tanaka, MD
Clinical pharmacology on Bay Street. A card stays in draft until she has checked the label numbers and cut counselling that would not survive a crowded evening clinic.
Meet the guideScan, Tag, Board-check, Post
Four passes before anything lands on the grid. A shortcut is how marketing copy sneaks onto a reference desk.
- Scan
Open the current label PDF and the named trials first. Another site's summary is not a source.
- Tag
Lock Suhagra, Hypernil, Stromectol, and the rest to their INNs before a highlight prints.
- Board-check
Dr. Yuki Tanaka asks whether a line earns ink or is decoration.
- Post
Stamp the review date, wire the links, place the card. Fresh regulator text sends it back to Tag.
The long version sits on the method page and the editorial standards.
Reference centres
Highlights have to point at a document you can open
Canadian monographs, US label PDFs, indexed trials, and WHO briefings. If a number cannot be traced, it does not stay on the card.
Open the centre list